Evidence map›Paper›PMID 34482048›Full record

ArticleDrug and alcohol dependence2021

Development and validation of a prediction model for opioid use disorder among youth.

Nicole M Wagner, Ingrid A Binswanger, Susan M Shetterly, Deborah J Rinehart, Kris F Wain, Christian Hopfer, Jason M Glanz

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Fatal overdose: Predicting to prevent.The International journal on drug policy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nicole M WagnerAdult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, 13199 E Montview Blvd, Suite 300, Aurora, CO, 80045, USA; Institute for Health Research, Kaiser Permanente Colorado, 2550 S. Parker Road, Suite 200, Aurora, CO, 80014, USA. Electronic address: Nicole.Wagner@cuanschutz.edu.
Ingrid A BinswangerInstitute for Health Research, Kaiser Permanente Colorado, 2550 S. Parker Road, Suite 200, Aurora, CO, 80014, USA; Colorado Permanente Medical Group, P.C., 10350 E. Dakota Ave., Denver, CO, 80247, USA; Division of General Internal Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, 12631 E 17thAve., Aurora, CO, 80045, USA. Electronic address: Ingrid.A.Binswanger@kp.org.
Susan M ShetterlyInstitute for Health Research, Kaiser Permanente Colorado, 2550 S. Parker Road, Suite 200, Aurora, CO, 80014, USA. Electronic address: Susan.Shetterly@kp.org.
Deborah J RinehartDivision of General Internal Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, 12631 E 17thAve., Aurora, CO, 80045, USA; Center for Health Systems Research, Denver Health Hospital and Authority, 777 Bannock St., M.C 6551, Denver, CO, 80204, USA. Electronic address: Deborah.Rinehart@dhha.org.
Kris F WainInstitute for Health Research, Kaiser Permanente Colorado, 2550 S. Parker Road, Suite 200, Aurora, CO, 80014, USA. Electronic address: Kris.F.Wain@kp.org.
Christian HopferDepartment of Psychiatry, School of Medicine, University of Colorado Anschutz, 13001 East 17thPlace, Q20-C2000, Aurora, CO, 80045, USA. Electronic address: Christian.Hopfer@cuanschutz.edu.
Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, 2550 S. Parker Road, Suite 200, Aurora, CO, 80014, USA; Department of Epidemiology, University of Colorado School of Public Health, 13001 East 17thPlace, 3rd Floor, Aurora, CO, 80045, USA. Electronic address: Jason.M.Glanz@kp.org.
Kaiser Permanente · USDenver Health Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

The Effects of Cannabis Legalization and Persistent Use: A Longitudinal Study of Two Twin CohortsR01DA042755 · NIDA · UNIVERSITY OF COLORADO DENVER · PI Jarrod Martin Ellingson, SOO H RHEE · 2017 to 2026
$9.9M
The Safety and Impact of Expanded Access to Naloxone in Health SystemsR01DA042059 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BINSWANGER, INGRID A, GLANZ, JASON M · 2016 to 2020
$3.6M
IMPlementation to Achieve Clinical Transformation (IMPACT): The Colorado Training ProgramK12HL137862 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GLASGOW, RUSSELL E, HAVRANEK, EDWARD PAUL · 2017 to 2021
$2.9M
Mentoring Clinical Investigators in Adolescent-onset Substance Use Disorders ResearchK24DA032555 · NIDA · UNIVERSITY OF COLORADO DENVER · PI HOPFER, CHRISTIAN J · 2013 to 2022
$1.9M
NHLBI NIH HHS K12 HL137862NIDA NIH HHS K24 DA032555NIDA NIH HHS R01 DA042059NIDA NIH HHS R01 DA042755
6 · The paper itself

Abstract

backgroundYouth are vulnerable to opioid use initiation and its complications. With growing rates of opioid overdose, strategies to identify youth at risk of opioid use disorder (OUD) to efficiently focus prevention interventions are needed. This study developed and validated a prediction model of OUD in youth aged 14-18 years.

methodsThe model was developed in a Colorado healthcare system (derivation site) using Cox proportional hazards regression analysis. Model predictors and outcomes were identified using electronic health record data. The model was externally validated in a separate Denver safety net health system (validation site). Youth were followed for up to 3.5 years. We evaluated internal and external validity using discrimination and calibration.

resultsThe derivation cohort included 76,603 youth, of whom 108 developed an OUD diagnosis. The model contained 3 predictors (smoking status, mental health diagnosis, and non-opioid substance use or disorder) and demonstrated good calibration (p = 0.90) and discrimination (bootstrap-corrected C-statistic = 0.76: 95 % CI = 0.70, 0.82). Sensitivity and specificity were 57 % and 84 % respectively with a positive predictive value (PPV) of 0.49 %. The validation cohort included 45,790 youth of whom, 74 developed an OUD diagnoses. The model demonstrated poorer calibration (p < 0.001) but good discrimination (C-statistic = 0.89; 95 % CI = 0.84, 0.95), sensitivity of 87.8 % specificity of 68.6 %, and PPV of 0.45 %.

conclusionsIn two Colorado healthcare systems, the prediction model identified 57-88 % of subsequent OUD diagnoses in youth. However, PPV < 1% suggests universal prevention strategies for opioid use in youth may be the best health system approach.

Indexed as

Opioid-Related DisordersAdolescentCalibrationCohort StudiesHumansPredictive Value of TestsSensitivity and SpecificityAdolescentOpioid use disorderPrediction modelPrognostic modelYouth

Identifiers

PMID34482048
PMCPMC8464513
OpenAlexW3196696160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.